Novel formylpeptide receptor 1/2 agonist limits hypertension-induced cardiovascular damage.
Singh J, Jackson KL, Fang H, Gumanti A, Claridge B, Tang FS, Kiriazis H, Salimova E, Parker AM, Nowell C, Woodman OL, Greening DW, Ritchie RH, Head GA, Qin CX.
Singh J, et al. Among authors: fang h.
Cardiovasc Res. 2024 Jun 16:cvae103. doi: 10.1093/cvr/cvae103. Online ahead of print.
Cardiovasc Res. 2024.
PMID: 38879891